Abel Hall LLC’s Lunai Bioworks LNAI Stock Holding History

Abel Hall LLC’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-215	Closed	-$9.32K	–	318
2025 Q1	$9.32K	Buy	215 +60	+39%	+$3.84K	0.01%	191
2024 Q4	$10.4K	Buy	+155	New	+$10.3K	0.01%	164

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Abel Hall LLC's LNAI Position: Q2 2025 in Review

Abel Hall LLC sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 215 shares — an estimated $9.32K sold.

Abel Hall LLC first reported a position in LNAI in Q4 2024 and held it in 2 quarters. The position peaked at $10.4K in Q4 2024. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

Abel Hall LLC reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
Abel Hall LLC sold 215 Lunai Bioworks shares in Q2 2025, an estimated $9.32K.
Abel Hall LLC first reported a position in Lunai Bioworks in Q4 2024 and held it in 2 quarters.
Abel Hall LLC's Lunai Bioworks position peaked at $10.4K in Q4 2024.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Abel Hall LLC's 13F filing for Q2 2025, filed 23 Jul 2025.